STOCK TITAN

Burning Rock Biotech (BNR) director lists indirect fund-held shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Burning Rock Biotech Ltd director Deng Feng filed an initial Form 3 reporting indirect holdings of the company’s Ordinary Shares. The filing shows positions held through Northern Light Venture Fund III, L.P., Northern Light Strategic Fund III, L.P., and Northern Light Partners Fund III, L.P.

These Cayman Islands partnerships are managed by Northern Light Venture Capital III, Ltd., where Deng Feng serves as director and makes investment decisions. He disclaims beneficial ownership of the reported securities for Section 16 purposes, except to the extent of any pecuniary interest.

Positive

  • None.

Negative

  • None.
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
DENG FENG

(Last)(First)(Middle)
UNIT 3203, CHINA CENTRAL PLACE
NO. 79 JIANGUO ROAD, CHAOYANG DISTRICT

(Street)
BEIJING100025

(City)(State)(Zip)

UNITED STATES

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026
3. Issuer Name and Ticker or Trading Symbol
Burning Rock Biotech Ltd [ BNR ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares10,542,529I(1)By Northern Light Venture Fund III, L.P.
Ordinary Shares1,188,025I(2)By Northern Light Venture Fund III, L.P.
Ordinary Shares149,691I(3)By Northern Light Venture Fund III, L.P.
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. These shares are owned directly by Northern Light Venture Fund III, L.P., or NLVF III, a Cayman Islands exempted limited liability partnership. Northern Light Venture Capital III, Ltd., or NLVC, is the general partner of Northern Light Partners III, L.P., which in turn is the general partner of NLVF III. The Reporting Person is the director of NLVC and makes investment decisions with respect to the securities held by NLVF III. The reporting person disclaims beneficial ownership of the securities reported herein for purposes of Section 16, except to the extent of his pecuniary interest therein, if any.
2. These shares are owned directly by Northern Light Strategic Fund III, L.P., or NLSF III, a Cayman Islands exempted limited liability partnership. NLVC is the general partner of Northern Light Partners III, L.P., which in turn is the general partner of NLSF III. The Reporting Person is the director of NLVC and makes investment decisions with respect to the securities held by NLSF III. The reporting person disclaims beneficial ownership of the securities reported herein for purposes of Section 16, except to the extent of his pecuniary interest therein, if any.
3. These shares are owned directly by Northern Light Partners Fund III, L.P., or NLPF III, a Cayman Islands exempted limited liability partnership, NLVC is the general partner of Northern Light Partners III, L.P., which in turn is the general partner of NLPF III. The Reporting Person is the director of NLVC and makes investment decisions with respect to the securities held by NLPF III. The reporting person disclaims beneficial ownership of the securities reported herein for purposes of Section 16, except to the extent of his pecuniary interest therein, if any.
Remarks:
Exhibit 24 (Power of Attorney)
/s/ Yuheng Huang, Attorney-in-Fact for Deng Feng03/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Deng Feng’s Form 3 filing for Burning Rock Biotech (BNR) show?

The Form 3 shows Deng Feng as a director with indirect holdings of Burning Rock Biotech Ordinary Shares through several Northern Light funds. It is an initial ownership report, not a record of new share purchases or sales.

How does Deng Feng hold Burning Rock Biotech (BNR) shares according to the Form 3?

The shares are held indirectly through Northern Light Venture Fund III, L.P., Northern Light Strategic Fund III, L.P., and Northern Light Partners Fund III, L.P. These Cayman partnerships are managed by Northern Light Venture Capital III, Ltd., where Deng Feng is a director.

Does the Burning Rock Biotech (BNR) Form 3 report any insider buying or selling?

The Form 3 records existing indirect holdings and uses holding-type entries with unknown transaction codes. It does not categorize any activity as buys or sells and functions as an initial statement of beneficial ownership for Section 16 reporting.

What ownership disclaimer does Deng Feng include in the Burning Rock Biotech (BNR) Form 3?

He disclaims beneficial ownership of the reported securities for Section 16 purposes, except to the extent of his pecuniary interest. This means economic interest may exist, but he does not claim full beneficial ownership of all shares held by the funds.

What role do Northern Light entities play in the Burning Rock Biotech (BNR) holdings?

Northern Light Venture Capital III, Ltd. is the general partner of entities that, in turn, are general partners of the Northern Light funds holding Burning Rock shares. As a director of this manager, Deng Feng makes investment decisions for those fund-held positions.
Burning Rock Biotech Ltd

NASDAQ:BNR

View BNR Stock Overview

BNR Rankings

BNR Latest News

BNR Latest SEC Filings

BNR Stock Data

200.47M
6.79M
Diagnostics & Research
Healthcare
Link
China
Guangzhou